These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31827650)

  • 1. Valuable Serum Markers in Pulmonary Alveolar Proteinosis.
    Shi S; Chen L; Qiu X; Zhao Q; Xiao Y; Yan X
    Dis Markers; 2019; 2019():9709531. PubMed ID: 31827650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated tumor markers in patients with pulmonary alveolar proteinosis.
    Fang SC; Lu KH; Wang CY; Zhang HT; Zhang YM
    Clin Chem Lab Med; 2013 Jul; 51(7):1493-8. PubMed ID: 23314555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis.
    Bai JW; Gu SY; Sun XL; Lu HW; Liang S; Xu JF
    BMC Pulm Med; 2022 Jan; 22(1):2. PubMed ID: 34980056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.
    Arai T; Inoue Y; Sugimoto C; Inoue Y; Nakao K; Takeuchi N; Matsumuro A; Hirose M; Nakata K; Hayashi S
    Respirology; 2014 Feb; 19(2):246-252. PubMed ID: 24251830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.
    Arai T; Hamano E; Inoue Y; Ryushi T; Nukiwa T; Sakatani M; Nakata K
    Respir Med; 2004 Dec; 98(12):1227-30. PubMed ID: 15588045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.
    Tazawa R; Trapnell BC; Inoue Y; Arai T; Takada T; Nasuhara Y; Hizawa N; Kasahara Y; Tatsumi K; Hojo M; Ishii H; Yokoba M; Tanaka N; Yamaguchi E; Eda R; Tsuchihashi Y; Morimoto K; Akira M; Terada M; Otsuka J; Ebina M; Kaneko C; Nukiwa T; Krischer JP; Akazawa K; Nakata K
    Am J Respir Crit Care Med; 2010 Jun; 181(12):1345-54. PubMed ID: 20167854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum markers in patients with idiopathic pulmonary alveolar proteinosis].
    Li Y; Tian X; Gui Y; Ma A; Li X; Zeng N; Zhang P; Li G; Xu K
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):497-501. PubMed ID: 25262689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
    Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J
    J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and safety of inhaled granulocyte-macrophage colony-stimulating factor therapy in idiopathic pulmonary alveolar proteinosis].
    Ding J; Xiao Y; Dai J; Miao L; Qiu Y; Chen L; Jiang H; Cai H
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2766-70. PubMed ID: 26711974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis.
    Seymour JF; Doyle IR; Nakata K; Presneill JJ; Schoch OD; Hamano E; Uchida K; Fisher R; Dunn AR
    Thorax; 2003 Mar; 58(3):252-7. PubMed ID: 12612307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis.
    Wylam ME; Ten R; Prakash UB; Nadrous HF; Clawson ML; Anderson PM
    Eur Respir J; 2006 Mar; 27(3):585-93. PubMed ID: 16507860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
    BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis.
    Seymour JF; Begley CG; Dirksen U; Presneill JJ; Nicola NA; Moore PE; Schoch OD; van Asperen P; Roth B; Burdach S; Dunn AR
    Blood; 1998 Oct; 92(8):2657-67. PubMed ID: 9763547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
    Wang P; Piao Y; Zhang X; Li W; Hao X
    Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis.
    Zhang F; Weng D; Su Y; Yin C; Shen L; Zhang Y; Zhou Y; Li Q; Hu Y; Li H
    Respir Res; 2020 Jan; 21(1):1. PubMed ID: 31898493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Statin Treatment for Pulmonary Alveolar Proteinosis without Hypercholesterolemia: A 12-Month Prospective, Longitudinal, and Observational Study.
    Shi S; Gui X; Ding J; Yang S; Xin X; Xu K; Xiao Y
    Biomed Res Int; 2022; 2022():1589660. PubMed ID: 36330458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of conventional tumor markers in young patients with pulmonary nodules.
    Xu L; Su Z; Xie B
    J Clin Lab Anal; 2021 Sep; 35(9):e23912. PubMed ID: 34296781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ; Tao Z; Gu W; Sun LH
    Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.